| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a187d64ba85668b95c608c7270e98c1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-12054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12113 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-08 |
| filingDate |
2004-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f151a3e4e54c2eadfaa0837e13ebbb6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7a3550125611449a2ff1df7685d9e86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f83fb279a4981006f91386975fbed29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9e46ae36731d999676807d9439c2aa3 |
| publicationDate |
2005-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2005193019-A |
| titleOfInvention |
Activable and bioactive implantable medical device and method of use thereof |
| abstract |
PROBLEM TO BE SOLVED: To provide an activatable and bioactive implantable medical device and method of use thereof. The medical device of the present invention is a medical device such as a vascular occlusion device or the like, wherein the device is placed at the top with a formulation that stimulates the production of various vascular endothelial growth factors. A support element, and a coating of the outer barrier, wherein the coating of the outer barrier is a solution of the formulation and bodily fluid until the outer barrier is dissolved by supplying a constant external material to the outer barrier. It acts to prevent certain reactions in between. [Selection] Figure 1 |
| priorityDate |
2003-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |